从高到低:ADHD药物和性功能障碍
Elijah W Hale1, Tyler J Igoe1, Oscar R Bernat1
1School of Medicine, University of Colorado, Aurora, CO 80045, United States.
The journal of sexual medicine
|April 7, 2025
概括
治疗ADHD的药物,尤其是兴奋剂,会影响青少年的性健康,男性更容易出现勃起功能障碍等问题. 非兴奋剂的副作用较少,强调了个性化治疗计划的必要性.
科学领域:
- 神经科学是一个神经科学.
- 青少年医学 青少年医学
- 精神病学是一个精神病学.
背景情况:
- 注意缺陷/多动症 (ADHD) 严重影响学术和社会发展.
- 患有ADHD的青少年面临高风险性行为 (HRSB) 和性功能障碍的风险增加.
- 药物对患有多动症的青少年性健康的影响尚未完全理解.
研究的目的:
- 调查ADHD治疗与青少年性功能障碍之间的关系.
- 为了比较兴奋剂与非兴奋剂ADHD药物的性副作用.
- 探索与ADHD治疗相关的性结果中的性别差异.
主要方法:
- 使用TriNetX电子医疗记录对超过60万名ADHD青少年进行了回顾性队列研究.
- 患者按兴奋剂,非兴奋剂或无药物使用分类,倾向性得分匹配.
- 通过ICD-10代码识别的性结果,包括HRSB,勃起功能障碍和失色症.
主要成果:
- 兴奋剂药物与增加的性欲和高性行为相关,特别是在男性中,男性也表现出更高的勃起功能障碍率.
- 服用兴奋剂的女性增加了避孕措施的使用和略高的性欲;非兴奋剂的女性呈现的性副作用较少.
- 观察到性功能障碍和HRSB的性别特异性差异.
结论:
- 临床医生必须在青少年ADHD治疗计划中考虑与兴奋剂相关的性副作用.
- 性别差异需要为男性和女性患者量身定制的干预措施.
- 需要进一步研究ADHD治疗对性健康的长期影响.
更多相关视频
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
5.6K
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
10.1K
相关概念视频
01:30Attention-Deficit/Hyperactivity Disorder
32
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
32
01:30Adrenergic Agonists: Therapeutic Uses
693
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
693
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
243
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
243
01:23Antidepressant Drugs: MAOIs and Other Agents
170
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
170
01:28Drug Therapy
32
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
32
01:28Adrenergic Agonists: Mixed-Action Agents
631
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
631